Crinetics Pharmaceuticals Files Q1 2025 10-Q
Ticker: CRNX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
CRNX Q1 2025 10-Q filed. Financials and ops update.
AI Summary
Crinetics Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial data points and disclosures related to their business operations are presented within this report.
Why It Matters
This filing provides investors with an update on Crinetics Pharmaceuticals' financial health and operational status for the first quarter of 2025, influencing investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Crinetics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of fiscal year 2025)
- 1231 — Fiscal Year End (Indicates the company's fiscal year concludes on December 31st)
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — Period of report
- 20250508 (date) — Filing date
- 6055 LUSK BLVD. SAN DIEGO, CA 92121 (address) — Business and mailing address
- 858-450-6464 (phone_number) — Business phone number
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the first quarter of 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20250508.
What is Crinetics Pharmaceuticals' primary business address?
The business address is 6055 LUSK BLVD., SAN DIEGO, CA 92121.
What is the Standard Industrial Classification (SIC) code for Crinetics Pharmaceuticals?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
The company's fiscal year ends on 1231.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Crinetics Pharmaceuticals, Inc. (CRNX).